Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma

International Journal of Cancer

Volumn 72, Issue 3, 1997, Pages 477-485

  Sharkey, Robert M ^a   Blumenthal, Rosalyn D ^a   Behr, Thomas M ^a   Wong, George Y ^b   Haywood, Lemuel ^a   Forman, Dan ^a   Griffiths, Gary L ^c   Goldenberg, David M ^a  

^a GARDEN STATE CANCER CENTER   (United States)

^b STRANG CANCER PREVENTION CENTER   (United States)

^c IMMUNOMEDICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY I 131; MONOCLONAL ANTIBODY Y 90; RADIOISOTOPE; RHENIUM 188;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IODINE RADIOISOTOPES; KIDNEY; KINETICS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RHENIUM; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 0030739164     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970729)72:3<477::AID-IJC16>3.0.CO;2-9     Document Type: Article

References (36)

1. ATTARD, A.R., CHAPPELL, M.J. and BRADWELL, A.R., Model-based calculation for effective cancer radioimmunotherapy. Brit. J. Radiol., 68, 636-645 (1995).
2. BEAUMIER, P.L., VENKATESAN, P., VANDERHEYDEAN, J.L., BURGUA, W.D., KUNZ, L.L., FRITZBURG, A.R., ABRAMS, P.G. and MORGAN, A.C., Re-186 radioimmunotherapy of small-cell-lung-carcinoma xenografts in nude mice. Cancer Res., 51, 676-681 (1991).
3. BEHR, T.M., SHARKEY, R.M., JUWEID, M.E., BLUMENTHAL, R.D., DUNN, R.M., GRIFFITHS, G.L., BAIR, H.J., WOLF, F.G., BECKER, W.S. and GOLDENBERG, D.M., Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res., 55, 3825-3834 (1995).
4. BEHR, T.M., SHARKEY, R.M., JUWEID, M.E., DUNN, R.M., VAGG, R.C., YING, Z., ZHANG, C.H., SWAYNE, L.C., VARDI, Y., SIEGEL, J.A. and GOLDENBERG, D.M., Phase- I/II clinical radioimmunotherapy with an I-131-anti-CEA murine IgG monoclonal antibody. J. Nucl. Med. (1997). (In press).
5. BLUMENTHAL, R.D., SHARKEY, R.M., FORMAN, D., WONG, G., HESS, J. and GOLDENBERG, D.M., Improved experimental cancer therapy by radioantibody-dose intensification as a result of syngeneic bone-marrow transplantation. Exp. Hematol., 23, 1088-1097 (1995).
6. BLUMENTHAL, R.D., SHARKEY, R.M., HAYWOOD, L., NATALE, A.M., WONG, G., SIEGEL, J.A., KENNEL, S.J. and GOLDENBERG, D.M., Targeted therapy of athymic mice bearing GW-39 human-colonic-cancer micrometastases with I-131-labeled monoclonal antibodies. Cancer Res., 52, 6036-6044 (1992).
7. BLUMENTHAL, R.D., SHARKEY, R.M., KASHI, R. and GOLDENBERG, D.M., Comparison of therapeutic efficacy and host toxicity of two different I-131-labeled antibodies and their fragments in the GW-39 colonic-cancer-xenograft model. Int. J. Cancer, 44, 292-300 (1989).
8. BLUMENTHAL, R.D., SHARKEY, R.M., NATALE, A.M., KASHI, R., WONG, G. and GOLDENBERG, D.M., Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic xenografts. Cancer Res., 54, 142-151 (1994).
9. 2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radio-immunotherapy of large human colon carcinoma grafted in nude mice. J. nucl. Med., 31, 1035-1044 (1990).
10. 2 fragments. J. clin. Invest., 83, 1449-1456 (1989).
11. 90Y-labeled monoclonal antibody 17-1A for treatment of human-colon-cancer xenografts. Int. J. Radiat. Oncol. Biol. Phys., 25, 629-638 (1993).
12. BUCHSBAUM, D.J., Experimental radioimmunotherapy and methods to increase therapeutic efficacy. In: D.M. Goldenberg, ed. Cancer Therapy with Radiolabeled Antibodies. CRC Press, Boca Raton, pp. 115-140 (1995).
13. 131I-labeled pan-B-cell monoclonal antibody in nude mice bearing Raji-Burkitt's-lymphoma xenograft. Cancer Res., 52, 6476-6481 (1992).
14. 2 and Fab′ in mice. Cancer Res., 46, 3969-3978 (1986).
15. GOLD, D.V., NOCERA, M.A., STEPHENS, R. and GOLDENBERG, D.M., Murine monoclonal antibodies to colon-specific antigen p. Cancer Res., 50, 6405-6409 (1990).
16. GOLDENBERG, D.M. and 14 OTHERS, Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J. clin. Oncol., 9, 548-564 (1991).
17. GRIFFITHS, G.L., GOLDENBERG, D.M., KNAPP, F.F., CALLAHAN, A.P., CHANG, C.H. and HANSEN, H.J., Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Cancer Res., 51, 4594-4602 (1991).
18. HIRD, V., MARAVEYES, A., SNOOK, D., DHOKIA, B., SOUTTER, W.P., MEARES, C., STEWART, J.S.W., MASON, P., LAMBERT, H.E. and EPENETOS, A.A., Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Brit. J. Cancer, 68, 403-406 (1993).
19. HOWELL, R.W., RAO, D.V. and SASTRY, K.S.R., Macroscopic dosimetry for radioimmunotherapy: non-uniform activity distributions in solid tumors. Med. Phys., 16, 66-74 (1989).
20. HUI, T.E., FISHER, D.R., KUHN, J.A., WILLIAMS, L.E., NOURIGAT, C., BADGER, C.C., BEATTY, B.G. and BEATTY, J.D., A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates. Cancer, 73, 951-957 (1994).
21. JUWEID, M., SHARKEY, R.M., SWAYNE, L.C., GRIFFITHS, G.L., DUNN, R., SIEGEL, J.A., KNAPP, F.F., JR. and GOLDENBERG, D.M., Pharmaeokinetics, dosimetry and toxicity of anti-CEA monoclonal antibody, MN-14, labeled with rhenium-188, in patients with gastrointestinal cancers. J. nucl. Med. (1997). (In press).
22. KAMINSKI, M.S., ZASADNY, K.R., FRANCIS, I.R., MILIK, A.W., ROSS, C.W., MOON, S.D., CRAWFORD, S.M., BURGESS, J.M., PETRY, N.A. and BUTCHKO, G.M., Radioimmunotherapy of B-cell lymphoma with I-131 anti-B1 (anti-CD20) antibody. New Engl. J. Med., 329, 459-465 (1993).
23. 131I-anti-carcinoembryonic-antigen therapy of LS174T human colonadenocarcinoma spheroids. Cancer Res., 49, 3401-3406 (1989).
24. MEARES, C.F., MCCALL, M.J., REARDON, D., GOODWIN, D., DIAMANTI, C.I. and MCTIGUE, M., Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromo-acetamide reagents, methods of analysis and subsequent addition of metal ions. Anal. Biochem., 142, 68-78 (1984).
25. MEREDITH, R.F., KHAZAELI, M.B., LIU, T., WHEELER, R.H., RUSSELL, C., COLCHER, D., SCHLOM, J., SHOCHAT, D. and LOBUGLIO, A.F., Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer. J. nucl. Med., 33, 1648-1653 (1992).
26. 131I-CC49 in colorectal cancer. Cancer, 73, (Suppl.), 1057-1066 (1994).
27. PANT, K.B., SHOCHAT, D., NELSON, M.O. and GOLDENBERG, D.M., Colon-specific antigen-p (CSAp). I: Initial clinical evaluation as a marker for colorectal cancer. Cancer, 50, 919-926 (1982).
28. PRESS, O.W. and 15 OTHERS, Treatment of refractory non-Hodgkin's lymphomas with radiolabeled MB-1 (anti-CD37) antibody. J. clin. Oncol., 7, 1027-1038 (1989).
29. SCHLOM, J., MOLINOLO, A., SIMPSON, J.F., SILER, K., ROSELLI, M., HINKLE, G., HOUCHENS, D.P. and COLCHER, D., Advantage of dose fractionation in monoclonal-antibody-targeted radioimmunotherapy. J. nat. Cancer Inst., 82, 763-771 (1990).
30. 171lutetium-labeled immunoconjugate. Cancer Res., 51, 2889-2896 (1991).
31. SHARKEY, R.M., GOLDENBERG, D.M., GOLDENBERG, H., LEE, R.E., BALLANCE, C., PAWLYK, D., VARGA, D. and HANSEN, H.J., Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic and targeting properties in humans. Cancer Res., 50, 2823-2831 (1990a).
32. SHARKEY, R.M. and 14 OTHERS, Clinical evaluation of tumor targeting with a high-affinity anti-carcinoembryonic-antigen-specific murine monoclonal antibody, MN-14. Cancer, 71, 2082-2096 (1993).
33. SHARKEY, R.M. and 12 OTHERS, Phase-I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas. Cancer, 73, 864-877 (1994).
34. SHARKEY, R.M., MOTTA-HENNESSY, C., PAWLYK, D., SIEGEL, J.A. and GOLDENBERG, D.M., Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human-colonic-tumor xenografts. Cancer Res., 50, 2330-2336 (1990b).
35. SHARKEY, R.M., PYKETT, M.J., SIEGEL, J.A., ALGER, E.A., PRIMUS, F.J. and GOLDENBERG, D.M., Radioimmunotherapy of the GW-39 human-colonic-tumor xenograft with I-131-labeled murine monoclonal antibody to carcino-embryonic antigen. Cancer Res., 47, 5672-5677 (1987).
36. 2 in nude mice bearing human tumor xenografts. Cancer, 73, 816-823 (1994).